Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 7935
TargetAdenosine receptor A3(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224619(US9326978, 32)
Affinity DataKi:  410nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224617(US9326978, 30)
Affinity DataKi:  786nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224618(US9326978, 31)
Affinity DataKi:  1.19E+3nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224621(US9326978, 34)
Affinity DataKi:  1.61E+3nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224617(US9326978, 30)
Affinity DataKi:  3.15E+3nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224617(US9326978, 30)
Affinity DataKi:  3.42E+3nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224618(US9326978, 31)
Affinity DataKi:  3.85E+3nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224619(US9326978, 32)
Affinity DataKi:  4.17E+3nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224620(US9326978, 49 | US9326978, 33)
Affinity DataKi:  4.69E+3nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224620(US9326978, 49 | US9326978, 33)
Affinity DataKi:  4.69E+3nMpH: 8.0Assay Description:Each tube in the competitive binding assay contained 100 μl membrane suspension (20 μg protein), 50 μl [125I]-AB-MECA (0.5 nM), and 50...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224618(US9326978, 31)
Affinity DataKi:  5.22E+3nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224620(US9326978, 49 | US9326978, 33)
Affinity DataKi: >1.00E+4nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A1(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224621(US9326978, 34)
Affinity DataKi: >1.00E+4nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224619(US9326978, 32)
Affinity DataKi: >1.00E+4nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224620(US9326978, 49 | US9326978, 33)
Affinity DataKi: >1.00E+4nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent

TargetAdenosine receptor A2a(Human)
The United States of America, Represented By The Secretary, Dept. of Health and Human Services

US Patent
LigandPNGBDBM224621(US9326978, 34)
Affinity DataKi: >1.00E+4nMpH: 7.4Assay Description:For binding to the human A1AR, [3H]R-PIA (2 nM) was incubated with membranes (40 μg/tube) from CHO cells stably expressing the human A1AR at 25°...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2017
Entry Details
Go to US Patent